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Summary
Formation of well-ordered crystals of membrane pro-
teins is a bottleneck for structure determination by
X-ray crystallography. Nevertheless, one can increase
theprobabilityof successful crystallizationbyprecrys-
tallization screening, a process by which one analyzes
the monodispersity and stability of the protein-deter-
gent complex. Traditionally, this has required micro-
gram to milligram quantities of purified protein and
a concomitant investment of time and resources.
Here, we describe a rapid and efficient precrystalliza-
tion screening strategy in which the target protein is
covalently fused to green fluorescent protein (GFP)
and the resulting unpurified protein is analyzed by
fluorescence-detection size-exclusion chromatogra-
phy (FSEC). This strategy requires only nanogram
quantities of unpurified protein and allows one to
evaluate localization and expression level, the degree
of monodispersity, and the approximate molecular
mass. We show the application of this precrystalliza-
tion screening to four membrane proteins derived
from prokaryotic or eukaryotic organisms.
Introduction
X-ray crystallography is currently the most powerful
technique for determining atomic resolution structures
of biological macromolecules (Hendrickson, 2000). The
resulting atomic structures, in turn, not only provide in-
sight into mechanism, but they may also accelerate
the discovery of therapeutic agents (Blundell et al.,
2002; Kuhn et al., 2002). In particular, the structures
of membrane proteins, including receptors, channels,
and transporters, are especially important because
these molecules are the targets of most drugs currently
prescribed (Zambrowicz and Sands, 2003). Unfortu-
nately, atomic resolution structural information on mem-
brane proteins is limited, as they are more difficult to
express and crystallize compared to water-soluble pro-
teins (Tate, 2001; Walian et al., 2004). In order to increase
the likelihood of obtaining crystals of a membrane pro-
tein, it is advantageous to not only optimize the expres-
sion conditions, but to also characterize the homogene-
ity of the protein prior to crystallization.
In a typical scenario, one embarks on an effort to crys-
tallize a new membrane protein by first examining differ-
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ence University, 3181 SW Sam Jackson Park Road, Portland, Ore-
gon 97239.ent expression systems and purification strategies, with
the aim of obtaining milligram quantities of purified pro-
tein. With purified protein in hand, one may then assess
the homogeneity of the sample, both in terms of chem-
ical composition and oligomerization state, by a variety
of techniques that might include SDS-PAGE, mass
spectrometry, light scattering, and size-exclusion chro-
matography (SEC). If the protein proves to be homoge-
nous, then one proceeds to crystallization. However, if
the protein is not homogenous or fails to crystallize,
then one may vary a number of parameters that might
include the detergent and/or lipids used in purification
and crystallization (Garavito and Ferguson-Miller, 2001;
le Maire et al., 2000; Long et al., 2005; Seddon et al.,
2004) and the nature of the protein construct (Cohen
et al., 1995), perhaps also exploring the properties of
proteins from other species (Kendrew, 1948, 1950; Ken-
drew and Parrish, 1956; Kendrew and Pauling, 1956).
Here, we refer to the aforementioned experiments as
‘‘precrystallization screening’’ (Figure 1).
In traditional precrystallization screening, one typi-
cally monitors the presence of the protein by absor-
bance at 280 nm and by staining on SDS-PAGE gels
(Figure 1A). To do this, however, microgram to milligram
quantities of the protein are required for reliable detec-
tion. Because almost all proteins, as well as nucleic
acids, absorb at 280 nm, the target protein must also
be free of major contaminants. Thus, a substantial in-
vestment in time and resources must be made in order
to bring a target molecule from the cloning stage to pre-
crystallization screening. Moreover, because many tar-
get molecules fail precrystallization screening, due to
polydispersity or instability, the time and resources in-
vested in the moderate- to large-scale expression and
purification of these proteins are wasted.
To obviate the requirement for moderate- to large-
scale expression and purification, we have developed
approaches that allow one to carry out precrystallization
screening on nanogram quantities of unpurified protein
obtained from whole-cell lysates or crude membrane
preparations of prokaryotic or eukaryotic cells (Fig-
ure 1B). Here, the target proteins are covalently fused
to green fluorescent protein (GFP) (Chalfie et al., 1994;
Shimomura et al., 1962; Zhang et al., 2002). The resultant
fusion proteins are monitored first for expression level
and pattern in whole cells by epifluorescence micros-
copy (eukaryotic cells) or batch fluorescence measure-
ments (prokaryotic cells). After solubilization of whole
cells or crude membranes, SEC profiles are monitored
by fluorescence spectroscopy. SEC is one of the most
useful tools for monitoring the monodispersity and sta-
bility of the target protein; a monodisperse and folded
protein will generally yield a single symmetrical Gauss-
ian peak, while a polydisperse, unstable, or unfolded
protein will typically yield multiple asymmetric peaks
(Barth et al., 1994; Ricker and Sandoval, 1996).
In this article, we present the methodology of precrys-
tallization screening by epi- and batch fluorescence, to-
gether with FSEC, followed by application of these
methods to a eukaryotic, oligomeric ion channel protein
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scribe the application of FSEC to the screening of tag
position and of stability in different detergents. Finally,
we evaluate Gaussian peak fitting of FSEC peak profiles
as a method for quantitatively evaluating the mono- or
polydispersity of a protein sample.
Results and Discussion
Covalent GFP Fusions
Our precrystallization screening methodology has two
facets. The first involves a series of new expression vec-
Figure 1. Flow Chart of Precrystallization Screening
(A) Traditional precrystallization screening. Variants of a target pro-
tein are expressed and purified on mid- to large scales to produce
microgram to milligram quantities. The resulting purified proteins
are characterized for monodispersity and stability by a series of bio-
chemical assays including immunostaining (IS), Western blotting
(WB), size-exclusion chromatography (SEC), and light scattering
experiments. This precrystallization screening is continued until
a promising construct is found.
(B) FSEC-based precrystallization screening. Variants of a target
protein are expressed as GFP fusions on a small scale and are char-
acterized directly by FSEC without purification. Here, the fusion pro-
teins are analyzed for expression level, monodispersity, approxi-
mate molecular mass, and stability.tors, for bacterial and mammalian cells, in which the tar-
get gene is covalently linked to GFP. Fused to the termi-
nus of GFP is a polyhistidine tag for affinity purification,
and inserted between the target protein and GFP is
a thrombin site for proteolytic cleavage of the target pro-
tein from GFP (Figure 2). Enhanced green fluorescent
protein (EGFP) is chosen for eukaryotic expression,
and GFPuv (Crameri et al., 1996) is chosen for bacterial
expression in order to (1) maximize the stability of the
chromophore in each expression system, (2) exploit
the stronger fluorescence signals in comparison to the
wild-type counterparts, and (3) utilize genes that have
codons optimized for each expression system (Crameri
et al., 1996; Haas et al., 1996; Heim et al., 1995). To reduce
GFP-mediated dimerization that might confound FSEC
analysis, alanine 206 in both GFP variants is mutated to
lysine (Zacharias et al., 2002). In all expression vectors,
multiple cloning sites (MCSs) are located at the 50 or 30
side of the GFP coding sequence so that the target pro-
tein can be tagged with GFP at its N or C terminus, re-
spectively. Because compatible MCSs are used for both
N- and C-terminal GFP fusion vectors for each expres-
sion system, one can readily screen N- and C-terminal-
tagged constructs by using the same PCR product.
The covalently fused GFP constructs allow one to vi-
sually inspect subcellular localization of proteins in
eukaryotic cells by fluorescence microscopy and to de-
termine protein expression in bacterial cells by batch
fluorescence. Moreover, polyhistidine and thrombin
sites in the GFP fusion vectors allow one to purify and
characterize the proteins from a small number of cells
and take advantage of the robust fluorescence from
GFP. These features profoundly benefit precrystalliza-
tion screening of integral membrane proteins whose ex-
pression levels are usually significantly lower than those
of soluble proteins.Figure 2. Maps of the GFP Fusion Vectors
(A) Eukaryotic expression vectors (pNGFP-
EU and pCGFP-EU). Transcription is driven
by a cytomegalovirus promoter (CMV) and
terminated by SV40 polyadenylation se-
quences.Sequencesencodingapolyhistidine
tag, a thrombin proteolysis site (Th), and en-
hanced green fluorescent protein (EGFP) are
located at either the 50 end or the 30 end of
the multiple cloning sites (MCS). The restric-
tion sites in the MCS, the stop codons, the
A206K mutation in EGFP, and the translation
initiation site (Kozak-ATG) are indicated.
(B) Bacterial expression vectors (pNGFP-BC
and pCGFP-BC). For the bacterial expression
vectors, transcription is directed by a T7 pro-
moter and terminated by a T7 terminator se-
quence. The coding sequence is designed
in the same way as for the eukaryotic expres-
sion vectors, except that a variant of uvGFP,
which has codons optimized for bacterial ex-
pression, is used instead of EGFP.
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Screening with GFP Fusion Proteins and
FSEC
(A) A gene of interest is amplified by PCR and
subcloned into one of the GFP fusion vectors.
Cells are either transfected or transformed
with the expression vectors and solubilized
with a detergent-containing buffer.
(B) The resulting crude cell lysate, after cen-
trifugation, is loaded directly onto an SEC
column. The SEC column eluent is then
passed through a flow-cell in a fluorometer
set to detect GFP fluorescence. In this sche-
matic, the FSEC setup includes a UV detector
and a fraction collector, elements that are
useful for running standards or for purifying
a fusion protein based on its fluorescence
profile. The panel labeled ‘‘Fluorescence’’ is
a hypothetical elution profile of a GFP fusion
protein detected by GFP fluorescence. The
panel labeled ‘‘UV absorbance’’ represents
a model of a typical UV absorbance pattern
from a crude cell lysate.Fluorescence-Detection Size-Exclusion
Chromatography
The second facet of our precrystallization screening
methodology involves a chromatography system fitted
with an SEC column and a fluorescence detector. With
this setup, one can monitor the elution of GFP fusion
proteins in the context of whole-cell lysates or solubi-
lized crude membranes (Figure 3). We call this method
fluorescence-detection SEC (FSEC). Here, we will focus
our attention on integral membrane proteins, although
one can carry out FSEC precrystallization screening on
water-soluble proteins as well.
For membrane proteins, crude membranes from bac-
terial cells or intact tissue culture cells are solubilized in
a detergent-containing solution, followed by a high-
speed centrifugation step (Figure 3A). The supernatant
is then directly applied to an SEC column equilibrated
in a detergent-containing solution, and the column is
connected to a fluorometer fitted with a flow cell (Fig-
ure 3B). FSEC is a powerful screening method because
the peak areas, profiles, and elution volumes provide in-
formation on (1) the expression level, (2) the degree of
monodispersity, and (3) the approximate molecular
mass of the fusion protein, respectively. Because FSEC
exploits the unique fluorescence signal of GFP, neither
protein purification nor large-scale culture is required;
readily obtainable fluorometers can detect w10 ng of
GFP. In the following sections, we describe the applica-
tion of our precrystallization screening strategy to four
different membrane proteins expressed in bacterial or
eukaryotic cells.
Precrystallization Screening of P2X Receptors
P2X receptors are eukaryotic integral membrane pro-
teins that form ion channels gated by ATP (Khakh,
2001; North, 2002). There are seven P2X receptor sub-
types (P2X1–7), and all subtypes except P2X6 form func-
tional channels when expressed in human embryonic
kidney (HEK) 293 cells. To determine whether any of
the rat P2X receptor subtypes would be suitable forcrystallization trials, we carried out precrystallization
screening with GFP fusion constructs. PCR products
of P2X1–5,7 genes were subcloned into either pCGFP-EU
or pNGFP-EU, and the resulting plasmids were trans-
fected into HEK293 cells. Two days after transfection,
the subcellular localizations of the P2X receptors were
checked by fluorescence microscopy (Figure 4A). On
the basis of visual inspection, the C-terminally-tagged
P2X constructs (C-P2Xs) expressed more robustly com-
pared to the N-terminally-tagged variants (N-P2Xs). In
the case of P2X3, both the N- and C-terminal variants re-
sulted not only in fluorescence at the plasma mem-
brane, but also in diffuse fluorescence in the cytoplasm,
the latter of which was presumably due to free GFP gen-
erated by adventitious proteolysis. For P2X4, the C-P2X4
variant appeared to express at the highest level and was
found in intracellular puncta, while the N-P2X4 construct
was found primarily on the cell surface. Although it is
possible that fusion of GFP to the receptor’s termini al-
ters trafficking or ion channel function, we note that
the approximate subcellular localizations of the C-termi-
nally-tagged P2X receptors observed in the present
study are consistent with previous observations (Boba-
novic et al., 2002). Moreover, electrophysiological and
ligand binding experiments have shown that the P2X4-
GFP fusions possess essentially wild-type behavior (Ka-
wate, 2005). Therefore, these data indicate that GFP fu-
sions are relatively benign perturbations to the receptor.
To more quantitatively evaluate the expression level
and the degree of monodispersity of the P2X constructs,
the N- and C-terminal GFP fusions were expressed in
transiently transfected HEK293 cells; one 35 mm dish
was used for each construct. The cells were solubilized
in a buffer containing the nonionic detergent n-dodecyl-
b-D-maltoside (C12M), and the resulting supernatant
was analyzed by FSEC. As shown in Figure 4B, the fluo-
rescence peak associated with the C-P2X4 construct
was much larger than the peaks from the other con-
structs, thus confirming the initial observation that C-
P2X4 expressed at a higher level than the other
Structure
676Figure 4. Precrystallization Screening of P2X Receptors by Epifluorescence and FSEC
(A) Fluorescence microscopic images of HEK293 cells expressing P2X-GFP fusion proteins. The images were taken 48 hr after transfection. The
scale bar is 100 mm.
(B) FSEC traces from P2X-GFP fusion proteins. The top panel shows the FSEC profiles of C-terminally tagged P2X1–5, 7 (C-P2X1–5, 7), and the
bottom panel shows those of N-terminally tagged P2X3–5 (N-P2X3–5), including C-P2X3 and C-P2X5. The arrows indicate the estimated elution
position of the void volume, a P2X oligomer (ca. trimer to hexamer), a monomeric P2X subunit, and free GFP, respectively. Note the difference
in scales for the top and bottom panels.constructs. For the C-P2X4 construct, the fluorescence
peak was nearly symmetric, the elution position of the
peak was suggestive of an oligomer, and there was
only a small peak at the void volume of the column.
The expression level of C-P2X4 was estimated as
w1 mg per 106 cells by using a standard curve derived
from known concentrations and fluorescence yields of
recombinant GFP.
The other fusion proteins, C-P2X5, C-P2X7, N-P2X4,
and N-P2X5, had reasonably symmetrical peak shapes,
but they all expressed at much lower levels (Figure 4B).
The C-P2X2 construct gave rise to a small but significant
peak at the void volume, suggesting that it had a ten-
dency to form high-molecular weight aggregates. Inter-
estingly, the C-P2X3 supernatant contained a substantial
amount of free GFP (Figure 4B, bottom panel), which
was consistent with the previous fluorescence micros-
copy (Figure 4A). Taken together, inspection of trans-
fected cells by fluorescence microscopy and analysis
of solubilized cells by FSEC suggest that the rat P2X4 re-
ceptor is a promising molecule for crystallization trials.
Precrystallization Screening of Bacterial
Homologs of Na+/Cl2-Dependent
Neurotransmitter Transporters
Na+/Cl2-dependent neurotransmitter transporters (NSS)
are integral membrane proteins that use ion gradients to
drive the uptake of a broad array of substrates, including
the biogenic amines, amino acids, and osmolytes (beta-
ine and creatine), into cells (Masson et al., 1999). In an
effort to obtain crystals of a bacterial homolog of an
NSS protein, genes corresponding to orthologs fromsix prokaryotic organisms (genes 1–6) were subcloned
into either pCGFP-BC (C-1, C-2, . C-6) or pNGFP-BC
(N-1, N-2, . N-6) vectors and screened by FSEC after
solubilization of crude membranes in a buffer containing
C12M. As shown in Figure 5A, the expression levels and
the degree of monodispersity of the C-terminal GFP fu-
sions varied substantially. Moreover, the expression
levels of constructs C-2 and C-6 were much greater
than those of C-1, C-3, C-4, and C-5. Interestingly, the
proteins that were more abundantly expressed yielded
more symmetric peaks, whereas those that were poorly
expressed gave less symmetric peaks, suggestive of ag-
gregation, misfolding, or heterogeneity in subunit stoi-
chiometry. The differences of the calculated molecular
masses of the fusion proteins are within 10%, yet pro-
teins C-1 and C-3 eluted significantly later than the other
proteins. One explanation for this behavior is that pro-
teins C-1 and C-3 were binding to the resin, perhaps
due to misfolding or partial unfolding. The FSEC traces
for the N-terminal fusions showed lower expression
levels compared to the C-terminal variants, suggesting
that tagging at the N terminus had a deleterious effect
on expression (data not shown).
On the basis of the FSEC screening, the target pro-
teins of the C-2 and C-6 constructs were subjected to
crystallization trials with proteins that were expressed
as non-GFP fusions. After affinity purification, the puri-
fied C-6 product was subjected to SEC detected by ab-
sorbance at 280 nm (Figure 5B). The qualitative similarity
of the FSEC (Figure 5A) and the SEC profiles indicates
that the GFP tag, as well as the purity and concentration
of the target protein, did not substantially affect the
Rapid Precrystallization Screening by FSEC
677Figure 5. Precrystallization Screening and
Structural Determination of a Bacterial Ho-
molog of Na+/Cl2-Dependent Neurotransmit-
ter Transporters
(A) FSEC traces from C-terminally tagged
bacterial homologs. Six different genes (1–6)
were screened by using the pCGFP-BC ex-
pression vector. The arrows indicate the
void volume and the elution volumes corre-
sponding to the molecular weights.
(B) SEC trace of the gene 6 product detected
by UV absorbance at 280 nm. After affinity pu-
rification, the target protein without GFP was
concentrated tow2 mg/ml and subjected to
SEC.
(C) Rod-shaped crystals of the gene 6 protein
are shown. The length of the bar is 200 mm.
(D) A diffraction image from a rod-shaped
crystal that diffracted beyond 2.8 A˚ resolu-
tion.
(E) A ribbon diagram of the gene 6 protein, a
sodium-dependent leucine transporter from
Aquifex aeolicus (Yamashita et al., 2005).monodispersity of the C-6 construct. In fact, the target
protein from the C-6 construct crystallized readily, yield-
ing crystals that diffracted beyond 1.7 A˚ resolution (Fig-
ures 5C–5E) (Yamashita et al., 2005).
Screening Tag Position by FSEC
Using traditional approaches to precrystallization
screening, we had previously obtained diffraction-qual-
ity crystals of the trimeric glutamate transporter homo-
log from Pyrococcus horikoshi (GltPh) expressed with
a C-terminally-tagged construct (Figures 6B and 6C)
(Yernool et al., 2004). Interestingly, N-terminally-tagged
variants of GltPh did not express as well as C-termi-
nally-tagged constructs and did not yield crystals
(data not shown). At the molecular level, inspection of
the GltPh crystal structure shows that the C terminus is
projecting away from the protein; thus, it appears that
the protein can accommodate a C-terminal tag. A mo-
lecular understanding of the difficulties encountered
with N-terminal tags is less clear, in part because the
first few residues of the protein cannot be reliably posi-
tioned in electron density. However, there are electron
density features that suggest that the N terminus makescontact with the protein core, and this may be why N-ter-
minal fusions are not tolerated.
To test whether FSEC can provide data to determine
optimal tag location, we cloned the GltPh gene into the
pCGFP-BC and pNGFP-BC E. coli expression vectors,
yielding the C-GltPh and N-GltPh constructs. Analysis of
crude solubilized membranes by FSEC (Figure 6A)
showed that while C-GltPh had a narrow and symmetric
peak, N-GltPh yielded a smaller and asymmetric peak,
suggestive of heterogeneity in subunit stoichiometry
and/or incomplete assembly. These results are consis-
tent with our previous observations made prior to the
development of FSEC technology. Therefore, the stud-
ies of the N- and C-terminal fusions of GltPh highlight
the importance of screening fusions at both ends of
the target protein, and they emphasize how FSEC pre-
crystallization analysis can provide important informa-
tion rapidly and easily.
Detergent Screening by FSEC
Successful crystallization of a membrane protein is of-
ten critically dependent on the detergent, and, in many
cases, the most well-ordered crystals are formed inFigure 6. Screening Tag Position by FSEC
(A) FSEC traces from either N- or C-terminally tagged GltPh, a eukaryotic glutamate transporter homolog from P. horikoshii. The transporter gene
was expressed with pCGFP-BC or pNGFP-BC, and the behaviors of these fusion proteins were examined by FSEC.
(B) Hexagonal crystals of GltPh protein are shown. The bar indicates 200 mm.
(C) A diffraction image from the hexagonal crystal. These crystals diffract anisotropically to ca. 3.2 A˚ along c* and to 3.8 A˚ along a*.
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micelles but that nevertheless maintains the protein in
a monodisperse and stable state (Michel, 1983; Oster-
meier and Michel, 1997). The traditional approach to
screening detergents involves purification of the mem-
brane protein of interest, exchange of the protein into
a panel of detergents, and subsequent evaluation of
the degree of monodispersity and stability. This tradi-
tional approach is exceptionally time and resource con-
suming, and, therefore, identifying optimal detergents is
one of the major technical obstacles for membrane pro-
tein crystallization. However, one can instead use FSEC
Figure 7. Detergent Screening by FSEC
FSEC analysis of protein J in six different detergents. The arrows in-
dicate the estimated elution position of the void volume, an oligomer
species (ca. trimer to hexamer), and free GFP. The substantial peak
due to free GFP may arise from either proteolysis of the fusion pro-
tein or from translation initiation at the methionine residue at the be-
ginning of the GFP coding sequence.to determine the degree of monodispersity and stability
of the target protein, without purification, by using whole-
cell lysates.
Here, we show a typical example of detergent screen-
ing by FSEC with the eukaryotic integral membrane pro-
tein J, a member of the ENaC/DEG family of ion channels
(Kellenberger and Schild, 2002). It was expressed in Sf9
insect cells by recombinant baculovirus infection as
a C-terminal GFP fusion (C-J). The baculovirus DNA
was created by site-specific transposition in E. coli cells
with a plasmid containing the entire coding region of
the fusion protein. C-J-expressing Sf9 cells were solubi-
lized in six detergents (C12M, n-decyl-b-D-maltoside
[C10M], n-octyl-b-D-glucoside [b-OG], octaethylene gly-
col monododecylether [C12E8], lauryl dimethylamine-
N-oxide [LDAO], and CHAPS), and after high-speed cen-
trifugation, the supernatants were analyzed by FSEC by
using a column equilibrated in C12M. In our experience,
we have found that the deleterious action of a destabiliz-
ing detergent is not ‘‘rescued’’ by a mild and typically
nondenaturing detergent such as C12M in the mobile
phase of the SEC column.
As shown in Figure 7, peak profiles from the solubi-
lized samples, except for those in b-OG and CHAPS,
were sharp and symmetrical, suggesting that the protein
was monodisperse in these detergents. In C12M, C12E8,
and LDAO, only a small fraction of the protein migrated
in the void volume of the column, thereby indicating that
the protein did not tend to aggregate under these condi-
tions. Significantly, the major peak of the C-J eluted at
a position that is consistent with a trimer or tetramer,
and previous studies have suggested a tetrameric sub-
unit stoichiometry for this class of proteins (Firsov et al.,
1998). In C10M, however, a significant fraction eluted in
the void volume despite the fact that the major peak
was still sharp and symmetrical. This observation sug-
gests that although C-J could be solubilized in this de-
tergent without disruption of its native association state,
it was only marginally stable in C10M. In fact, when the
peak fraction was reanalyzed by FSEC after 3 days at
4ºC, most of the protein eluted in the void volume
(data not shown). When C-J was analyzed after solubili-
zation in b-OG and CHAPS, the major fluorescenceFigure 8. Gaussian Peak Fitting of the FSEC Trace
(A and B) Fitting of FSEC traces of C-GltPh and N-GltPh with Gaussian functions ([A], C-GltPh; [B], N-GltPh). The black lines indicate the separate
Gaussian functions, and the colored lines represent the sum of the individual functions (red, C-GltPh; blue, N-GltPh). Note that only the FSEC
traces between 1000 s and 2500 s were used for the peak fittings, and that the experimental trace superimposes on the colored lines representing
the sum of the individual Gaussian functions. The Gaussian functions derived from the fusion proteins are labeled with numbers, and the func-
tions for GFPs are labeled as ‘‘GFP.’’ The Gaussian function number 3 in N-GltPh is labeled in magenta for emphasis.
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two detergents were not suitable for maintaining C-J in
a stable, monodisperse state. In conclusion, these stud-
ies suggested that C12M, C12E8, and LDAO were the
most promising detergents for purification and crystalli-
zation of the C-J.
Gaussian Peak Fitting as a Tool for
FSEC Peak Validation
In many cases, simple visual inspection of FSEC profiles
can allow one to estimate the expression level and de-
gree of monodispersity of a target protein. However,
there are instances when visual inspection is inade-
quate. Since peak shapes of monodisperse proteins
eluting from an ideal size-exclusion chromatography
column obey Gaussian distributions, the peak(s) corre-
sponding to the target protein can be fit to Gaussian
functions. Depending on the extent to which more than
one function is required to fit the peak in question, one
can then estimate whether a particular peak is com-
posed of more than one species (Barth et al., 1994).
For example, if a given peak from a FSEC trace requires
multiple Gaussians to achieve a reasonable fit, then it is
likely that the target protein is correspondingly hetero-
geneous in aggregation or association state and is
thus not suitable for crystallization trials. Although
Gaussian fitting of chromatographic peaks may not al-
ways be ideal due to broadening processes reflective
of extra-column volumes, axial diffusion, dispersion,
and solute and resin interactions (Popovici et al., 2004;
Stulik et al., 2003), it is a robust and rapid way to visual-
ize and quantify the possible peaks underlying a specific
FSEC trace.
As one example, we fit the profiles of C-GltPh and
N-GltPh with multiple Gaussian functions. As shown in
Figure 8 and Table 1, the C-GltPh trace was adequately
fit to three Gaussians (peaks 1 and 2 and GFP), while
the N-GltPh trace required four (peaks 1–3 and GFP).
Therefore, the major difference between the two con-
structs is that the N-GltPh construct has a substantial
third peak that likely corresponds to monomeric sub-
units of the transporter (Figure 8B, peak 3). Interestingly,
peak fitting of both the N-GltPh and C-GltPh profiles sug-
gests that the major peak may have a second compo-
nent (Figures 8A and 8B, peak 2). At this point, it is not
clear whether peak 2 actually represents a discrete en-
tity or whether it is merely a reflection of nonideal migra-
tion on the column. Nevertheless, this analysis demon-
strates that the C-GltPh construct is less polydisperse
than the N-GlutPh construct; therefore, it is a more prom-
ising species for crystallization trials.
FSEC versus SEC
For a variety of proteins we have tested so far, the FSEC
profiles of the fusion proteins were similar to the SEC
profiles of the purified nonfusion proteins (e.g., Figures
5 and 6). However, we have encountered a few situa-
tions where fusion with GFP does alter the behavior of
the target protein, thereby compromising the utility of
the FSEC approach. Additionally, when SEC is per-
formed on more concentrated purified proteins, the pro-
files may differ from those of FSEC because this latter
technique is typically carried out on diluted samples.
Nevertheless, in our experience, these occurrences arerare, and they do not outweigh the great advantages of
a fluorescence-based precrystallization screening strat-
egy. Therefore, in the initial steps of a crystallography
project, FSEC is an efficacious and practical method
for precrystallization screening of integral membrane
proteins.
Conclusions
X-ray crystallography of integral membrane proteins is
problematic because finding a membrane protein that
will yield diffraction-quality crystals requires a substan-
tial investment in time and resources. However, we have
shown that unproductive large-scale protein expression
and purification can be minimized by fluorescence-
detection size-exclusion chromatography (FSEC), a rapid
precrystallization screening method in which monodis-
persity and stability of the target protein are character-
ized with only nanogram quantities of unpurified protein.
In this method, the target protein is covalently fused to
GFP, and the resulting unpurified fusion protein is ana-
lyzed by SEC. Although the GFP fusion technique has
been used previously to monitor bacterial membrane
protein expression and to screen detergents used for
solubilization (Drew et al., 2001, 2005), to our knowledge
it is novel to combine covalent GFP fusion and SEC
techniques to analyze monodispersity and stability of
the fusion protein for protein crystallization. Moreover,
FSEC-based precrystallization screening may be ex-
ploited with the previously described GFP fusion ap-
proach to establish cell lines possessing high expres-
sion levels of promising constructs (Mancia et al., 2004).
In this report, the advantages and significance of co-
valent GFP fusion proteins and FSEC precrystallization
screening were demonstrated in examples with eukary-
otic and prokaryotic membrane proteins. In these exper-
iments, small amounts of unpurified target membrane
proteins were rapidly and easily evaluated for localiza-
tion and expression level, the degree of monodispersity,
the approximate molecular mass, and stability in deter-
gents. The utility of this approach is further emphasized
by its successful application to a bacterial integral mem-
brane transport protein that yielded crystals that dif-
fracted beyond 1.7 A˚ resolution.
Experimental Procedures
GFP Fusion Vector Construction
The eukaryotic GFP fusion vectors (pCGFP-EU and pNGFP-EU)
were created by using standard molecular biology techniques start-
ing with the pEGFP-C1 vector obtained from Clontech. Briefly, the
Table 1. Peak Fitting Summary of C-GltPh and N-GltPh
r2 CDa DOF r2b Fit SEc F Valued
C-GltPh 0.999 0.999 587.0 1.80 3 10
6
N-GltPh 0.999 0.999 424.7 6.71 3 10
5
SSE, sum of squared errors; SSM, sum of squares about the mean;
n, total number of data values; m, the number of coefficients in the
model.
a r2 coefficient of determinant, r2 = 1 2 SSE/SSM.
b Degree of freedom-adjusted coefficient of determination, DOF r2 =
(1 2 SSE*[n 2 1])/(SSM*[DOF 2 1]).
c Fit standard error, SE = sqrt(SSE/DOF).
d F value = ([SSM 2 SSE]/[m 2 1])/(SSE/DOF).
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680original multiple cloning site (MCS) was replaced with either an oc-
tahistidine coding sequence (His8) for pCGFP-EU or with a thrombin
recognition site coding sequence (TRS) followed by a new MCS
(XhoI-HindIII-EcoRI-PstI-SalI) for pNGFP-EU. The NheI and NotI
sites at the 50 side of the EGFP sequence were used to introduce ei-
ther the new MCS and TRS for pCGFP-EU or the His8 sequence for
pNGFP-EU. To minimize EGFP dimerization, alanine 206 was mu-
tated to a lysine residue by PCR.
The N-terminal bacterial GFP fusion vector (pNGF-BC) was cre-
ated by inserting GFPuv into the pET22c (Novagen) vector, together
with the His8 and TRS described above. The original GFPuv coding
sequence was obtained from a plasmid containing GFPuv kindly
gifted from Dr. John Hunt, and it was modified by PCR to (1) change
alanine 206 to a lysine, to (2) remove XhoI, BamHI, HindIII, and NcoI
sites, and to (3) add a polyasparagine linker at the 30 end (GFPuv-b).
The SpeI site in the pET22c vector was knocked out by PCR, and
a His8-TRS was inserted into the pET22c vector between the NdeI
and NcoI sites (pET22c-b). Subsequently, the MCS in pET22c-b be-
tween the BamHI and XhoI sites was replaced by a pair of synthetic
oligos in order to introduce a stop codon after the XhoI site
(pET22c-g). Finally, GFPuv-b was inserted into pET22c-g between
the AgeI and SpeI sites to produce pNGFP-BC.
The C-terminal bacterial GFP fusion vector (pCGFP-BC) was cre-
ated by using GFPuv-b and pET25b (Novagen). Briefly, a pelB leader
peptide sequence was removed from pET25b by a pair of synthetic
oligos (pET25b-b). TRS and His8 coding sequences were added to
GFPuv-b at its 50 and 30 ends, respectively, by PCR, and inserted be-
tween the XhoI and NheI sites of pET25b-b. In order to make the
MCS of pCGFP-BC compatible with that of pNGFP-BC, a NcoI site
was knocked out, and the NdeI site was converted to a new NcoI
site by PCR. The resulting MCS includes NcoI, BamHI, EcoRI,
SacI, SalI, HindIII, NotI, and XhoI sites. Finally, the first Met in GFPuv
was mutated to Val to minimize internal translation initiation.
FSEC for P2X Receptors
HEK293 cells were cultured to w90% confluency in a 6-well plate
(Corning) and transiently transfected with the specific expression
constructs (1 mg/well) by using Lipofectamine 2000 (3–5 ml, Invitro-
gen) as instructed by the manufacturer. After incubating for 24–48
hr, the cells were harvested by gentle pipetting, washed with PBS,
and resuspended in 500 ml solubilization buffer (PBS [pH 8.0], 20
mM C12M, and 1 ml protease inhibitor cocktail set III [Calbiochem]).
The resulting suspension was rotated for 1 hr at 4ºC, followed by
centrifugation at 66,0003 g for 40 min. A fraction of the supernatant
(200 ml) was loaded onto a Superose 6 column (10/30, Amersham
Biosciences) preequilibrated with SEC buffer (20 mM Tris [pH 8.0],
150 mM NaCl, 1 mM EDTA, and 1 mM C12M) and run at a flow rate
of 0.5 ml/min. The eluent from the SEC column was passed through
a fluorometer fitted with a flow cell. The fluorometer settings were as
follows: band pass, 3 nm/3 nm; excitation, 488 nm; emission, 507
nm; time increment, 1 s; integration time, 1 s; recording time,
3000–3600 s. Calibration with known quantities of GFP demon-
strated that 1–10 ng GFP could readily be detected.
FSEC for Bacterial Proteins
The desired expression vector was transformed into BL21(DE3)
pLysS-competent cells by using standard methods, and the result-
ing cells were plated onto LB agar plates supplemented with ampi-
cillin and chloramphenicol. After incubation forw16 hr at 37ºC, a sin-
gle colony was picked and used to inoculate 10 ml LB medium
containing 50 mg/ml ampicillin and 34 mg/ml chloramphenicol. Cells
were cultured in a shaker at 37ºC. When the OD600 reachedw0.6, ex-
pression was induced by the addition of 1 mM IPTG, and the cells
were grown for an additional 3 hr. The cells were collected by centri-
fugation, resuspended in 500 ml sonication buffer (50 mM Tris-HCl
[pH 8.0], 190 mM NaCl, 10 mM KCl, 15 mM EDTA, 10 mg/ml lysozyme,
and 100 mM PMSF), and disrupted by sonication on ice. Sonication
was repeated four times with 1 min intervals by using VirSonic475
(Virtis) in which each cycle was programmed as follows: sonication
time, 1 s; interval, 1 s; total sonication time, 10 s. The sonicated sam-
ple was first centrifuged at 10,000 3 g for 15 min to pellet unbroken
cells, and then the membranes were collected by a second centrifu-
gation at 200,000 3 g for 20 min. The membrane pellet (w5–20 mg)
was solubilized with 500 ml solubilization buffer 1 (50 mM Tris-HCl[pH 8.0], 190 mM NaCl, 10 mM KCl, 15 mM EDTA, 100 mM PMSF,
and 40 mM C12M) and gently mixed at 4ºC for at least 1 hr, followed
by centrifugation at 200,0003 g for 20 min. A fraction of the resulting
supernatant (200 ml) was loaded onto a Superose 6 10/30 column
preequilibrated in running buffer (20 mM Tris-HCl [pH 8.0], 190 mM
NaCl, 10 mM KCl, 1 mM C12M) and run at the flow rate of 0.5 ml/min.
The eluent was detected by a fluorometer as described above, with
the only difference being the excitation wavelength (395 nm) and
emission wavelength settings (507 nm).
Detergent Stability Screening of a Eukaryotic
Membrane Protein J
Eukaryotic membrane protein J was expressed in Sf9 cells by bacu-
lovirus infection for 72 hr at 27ºC by using standard methods. The
baculovirus was created from pFastBac (Invitrogen) in which the en-
tire coding sequence of C-terminally-tagged protein J from pCGFP-
EU vector was inserted between the BamHI and HindIII sites. Cells
from 1 ml of culture were collected by centrifugation and solubilized
in 300 ml PBS (Cellgro) containing one of the following detergents,
where the final detergent concentration is given in parentheses:
C12M (20 mM), C10M (20 mM), b-OG (250 mM), C12E8 (20 mM),
LDAO (20 mM), and CHAPS (125 mM). Solubilization was carried
out for 1 hr at 4ºC with gentle rotation. After centrifugation at
66,000 3 g for 40 min, 200 ml of the soluble fraction was loaded
onto a Superose 6 10/30 column preequilibrated with running buffer
(20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM C12M), and FSEC was
carried out as described above.
Gaussian Peak Fitting
Fluorescence values between 1000 s and 2500 s on the FSEC traces
of C-GltPh and N-GltPh were imported to PeakFit software (SeaSolve
Software, Inc). Initial peak detection and fitting were done by the re-
sidual method, and the Gaussian functions were further fitted to the
original peaks by using a least squares minimization algorithm with
iteration cycles of 61 (C-GltPh) and 34 (N-GltPh). The resulting
Gaussian peaks were validated by the r2 coefficient of the determi-
nant, the degree of freedom-adjusted coefficient of determination,
the fit standard error, and the F value.
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